In another study, the co‐treatment of eugenol and cisplatin reduced cell proliferation and induced apoptosis in G361 melanoma cells via inhibited MMP and proteasome activity, increased Bax and caspase‐9/7/3 expression, and declined Bcl‐2 expression (Park et al. 2011). Here, BCL2 is linked to melanoma.